Motive Wealth Advisors Exact Sciences Corp Transaction History

Motive Wealth Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$56.27 - $73.77 $163,633 - $214,523	2,908 New	2,908 $200,000
Q1 2022 May 03, 2022	SELL	$57.56 - $82.54 $177,687 - $254,800	-3,087 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$72.5 - $100.68 $870 - $1,208	-12 Reduced 0.39%	3,087 $240,000
Q3 2021 Nov 16, 2021	BUY	$90.24 - $124.05 $3,068 - $4,217	34 Added 1.11%	3,099 $296,000
Q2 2021 Aug 16, 2021	BUY	$93.66 - $139.27 $287,067 - $426,862	3,065 New	3,065 $381,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Motive Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Motive Wealth Advisors with notifications on news.